Haleon (HLN) Acquisitions (2021 - 2025)

Haleon's (HLN) quarterly Acquisitions came in at $905.7 million in Q4 2025, up 1127.79% on a QoQ basis from -$88.1 million in Q4 2023.

Haleon (HLN) Acquisitions (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Acquisitions data on file, last reported at $905.7 million in Q4 2025.

Quarterly Acquisitions changed N/A year-over-year to $905.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 billion (changed N/A YoY) and the FY2024 annual result came in at $2.9 billion, up 3356.79% from the prior year.
Acquisitions improved to $905.7 million in Q4 2025, from -$88.1 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $1.6 billion in Q3 2022 to a low of -$88.1 million in Q4 2023.
A 4-year average of $885.1 million and a median of $905.7 million in 2025 frame the typical range for Acquisitions.
Annual changes were most pronounced in 2022 — Acquisitions soared 289.51% — and 2023, when it plunged 105.63%.
Tracing HLN's Acquisitions over 4 years: stood at $401.7 million in 2021, then soared by 289.51% to $1.6 billion in 2022, then tumbled by 105.63% to -$88.1 million in 2023, then soared by 1127.79% to $905.7 million in 2025.
The last three Acquisitions figures came in at $905.7 million (Q4 2025), -$88.1 million (Q4 2023), and $1.6 billion (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	-
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Alkermes	8.12 Bn	7.46 Bn	397.90 Mn	-

Download Data